Qiagen N.V. (QGEN)
NYSE: QGEN · Real-Time Price · USD
39.85
+0.20 (0.50%)
At close: Mar 28, 2025, 4:00 PM
39.61
-0.25 (-0.61%)
After-hours: Mar 28, 2025, 4:59 PM EDT
Qiagen Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Qiagen stock have an average target of 49.79, with a low estimate of 42 and a high estimate of 55.62. The average target predicts an increase of 24.94% from the current stock price of 39.85.
Analyst Consensus: Buy
* Price targets were last updated on Feb 19, 2025.
Analyst Ratings
The average analyst rating for Qiagen stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 4 | 4 | 4 | 3 | 2 | 2 |
| Hold | 4 | 4 | 3 | 3 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Baird | Baird | Buy → Hold Downgrades $52 → $42 | Buy → Hold | Downgrades | $52 → $42 | +5.40% | Feb 19, 2025 |
| UBS | UBS | Hold Maintains $50 → $48 | Hold | Maintains | $50 → $48 | +20.45% | Feb 7, 2025 |
| Morgan Stanley | Morgan Stanley | Buy → Hold Downgrades $52 → $49 | Buy → Hold | Downgrades | $52 → $49 | +24.07% | Jan 6, 2025 |
| Jefferies | Jefferies | Hold → Strong Buy Initiates $43 → $56 | Hold → Strong Buy | Initiates | $43 → $56 | +39.57% | Dec 10, 2024 |
| HSBC | HSBC | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 17, 2024 |
Financial Forecast
Revenue This Year
2.08B
from 1.98B
Increased by 5.15%
Revenue Next Year
2.22B
from 2.08B
Increased by 6.49%
EPS This Year
2.35
from 0.37
Increased by 534.03%
EPS Next Year
2.56
from 2.35
Increased by 9.32%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.3B | 2.5B | 2.7B | ||
| Avg | 2.1B | 2.2B | 2.4B | ||
| Low | 2.0B | 2.1B | 2.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.6% | 21.6% | 23.3% | ||
| Avg | 5.1% | 6.5% | 7.1% | ||
| Low | -0.4% | -0.8% | -2.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.70 | 3.12 | 3.48 | ||
| Avg | 2.35 | 2.56 | 2.84 | ||
| Low | 2.21 | 2.33 | 2.55 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 629.7% | 33.0% | 35.6% | ||
| Avg | 534.0% | 9.3% | 10.6% | ||
| Low | 495.9% | -0.6% | -0.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.